Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
1
Bearish filings
206
Named actors
27
Disclosed $ (bull / bear)
$318K / $361.1M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-21 | Chief Business Officer Adair Jason | sold | $2.9M | SEC ↗ |
| 2026-08-21 | Chief Business Officer Adair Jason | sold | $2.2M | SEC ↗ |
| 2026-08-21 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JASON ADAIR | filed notice to sell | $5.2M | SEC ↗ |
| 2026-08-20 | Director Rielly-Gauvin Katherine | sold | $1.3M | SEC ↗ |
| 2026-08-19 | Chief Medical Officer Saggar Rajeev | sold | $3.7M | SEC ↗ |
182 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-19 | Director Rielly-Gauvin Katherine | sold | $2.8M | SEC ↗ |
| 2026-08-19 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) RAJEEV SAGGAR | filed notice to sell | $3.7M | SEC ↗ |
| 2026-08-19 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) Katherine T. Rielly-Gauvin | filed notice to sell | $4.1M | SEC ↗ |
| 2026-08-17 | Chief Medical Officer Saggar Rajeev | sold | $2.3M | SEC ↗ |
| 2026-08-17 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) RAJEEV SAGGAR | filed notice to sell | $2.3M | SEC ↗ |
| 2026-07-23 | Director Bloch Stephen M | sold | $327K | SEC ↗ |
| 2026-07-23 | Director Bloch Stephen M | sold | $8.6M | SEC ↗ |
| 2026-07-22 | Director Bloch Stephen M | sold | $1.3M | SEC ↗ |
| 2026-07-22 | Director Bloch Stephen M | sold | $4.3M | SEC ↗ |
| 2026-07-22 | Director Bloch Stephen M | sold | $3.3M | SEC ↗ |
| 2026-07-21 | Director Bloch Stephen M | sold | $45K | SEC ↗ |
| 2026-07-21 | Director Bloch Stephen M | sold | $6.0M | SEC ↗ |
| 2026-07-20 | Director Bloch Stephen M | sold | $286K | SEC ↗ |
| 2026-07-13 | Chief Accounting Officer Boyle Dana | sold | $46K | SEC ↗ |
| 2026-07-13 | Chief Accounting Officer Boyle Dana | sold | $598K | SEC ↗ |
| 2026-07-13 | Chief Commercial Officer Moomaw Scott | sold | $48K | SEC ↗ |
| 2026-07-13 | Chief Commercial Officer Moomaw Scott | sold | $634K | SEC ↗ |
| 2026-07-13 | Chief Medical Officer Saggar Rajeev | sold | $50K | SEC ↗ |
| 2026-07-13 | Chief Medical Officer Saggar Rajeev | sold | $660K | SEC ↗ |
| 2026-07-13 | General Counsel Schundler Russell | sold | $979K | SEC ↗ |